May 24, 2016 5:23 AM ET


Company Overview of Neogenix Oncology, Inc.

Executive Profile

Philip M. Arlen M.D.

Chief Executive Officer, President, Chief Medical Officer and Director, Neogenix Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Philip M. Arlen, M.D. serves as the Chief Executive Officer of Precision Biologics, Inc. Dr. Arlen has been the Chief Executive Officer of Neogenix Oncology Inc., since March 2010 and its President and Chief Medical Officer since September 28, 2008. He focused on the clinical development program for Neogenix Oncology's novel monoclonal antibody, NPC-1C, which was intended for the treatment of pancreatic cancer. In addition, he plays an integral role in the R&D effort ...

Corporate Headquarters

445 Northern Boulevard
Great Neck, New York 11021

United States

Phone: 516-482-1200
Fax: 516-482-3848

Board Members Memberships

Chief Executive Officer, President, Chief Medical Officer and Director


Emory University
Medical College Of Georgia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neogenix Oncology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at